Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve

Background— Transcatheter aortic valve implantation was developed to mitigate the mortality and morbidity associated with high-risk traditional aortic valve replacement. The Edwards SAPIEN valve was approved for transcatheter aortic valve implantation transfemoral delivery in the European Union in November 2007 and for transapical delivery in January 2008. Methods and Results— The SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry was designed to assess the initial clinical results of the Edwards SAPIEN valve in consecutive patients in Europe after commercialization. Cohort 1 consists of 1038 patients enrolled at 32 centers. Patients who were treated with the transapical approach (n=575) suffered more comorbidities than the transfemoral patients (n=463), resulting in a significantly higher logistic EuroSCORE (29.1% versus 25.7%; P<0.001). Therefore, these groups are considered different, and outcomes cannot be compared. Overall short-term procedural success was observed in 93.8%. The incidence of valve embolization was 0.3% (n=3), and coronary obstruction was reported for 0.6% (n=6 cases). Incidence of stroke was 2.5% and similar for both procedural approaches. Thirty-day mortality was 6.3% in transfemoral patients and 10.3% in transapical patients. The occurrence of vascular complications was not a predictor of <30-day mortality in the transfemoral population. Conclusion— Technical proficiency can be learned and adapted readily as demonstrated by the short-term procedural success rate and low 30-day mortality rates reported in the SOURCE Registry. Specific complication management and refinement of patient selection are needed to further improve outcomes.

[1]  J. Légaré,et al.  Journal of Cardiothoracic Surgery Open Access the European System for Cardiac Operative Risk Evaluation (euroscore) Is Not Appropriate for Withholding Surgery in High-risk Patients with Aortic Stenosis: a Retrospective Cohort Study , 2022 .

[2]  R. Bauernschmitt,et al.  Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  T. Felderhoff,et al.  Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System , 2008, Circulation. Cardiovascular interventions.

[4]  Sean M. O'Brien,et al.  Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. , 2009, The Journal of thoracic and cardiovascular surgery.

[5]  M. Cheitlin United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex , 2009 .

[6]  Sean M. O'Brien,et al.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. , 2009, The Annals of thoracic surgery.

[7]  M. Mack,et al.  Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. , 2008, The Journal of thoracic and cardiovascular surgery.

[8]  J. Maillet,et al.  Frailty after aortic valve replacement (AVR) in octogenarians. , 2009, Archives of gerontology and geriatrics.

[9]  Fabian Nietlispach,et al.  Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes , 2009, Circulation.

[10]  Martyn Thomas,et al.  Transcatheter aortic valve implantation (TAVI): how to interpret the data and what data is required? , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  L. Cohn,et al.  Partial upper re-sternotomy for aortic valve replacement or re-replacement after previous cardiac surgery. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  F. Mohr,et al.  Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. , 2009, The Annals of thoracic surgery.

[13]  A. Cheung,et al.  Atrioventricular block after transcatheter balloon expandable aortic valve implantation. , 2008, JACC. Cardiovascular interventions.

[14]  Robert E Harbaugh,et al.  Surgeon Volume and Operative Mortality in the United States. , 2004, Neurosurgery.

[15]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.

[16]  Volkmar Falk,et al.  Transapical minimally invasive aortic valve implantation; the initial 50 patients. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  D. Capodanno,et al.  Early Conduction Disorders Following Percutaneous Aortic Valve Replacement , 2009, Pacing and clinical electrophysiology : PACE.

[19]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[20]  J. Monro,et al.  Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. , 2008, The Annals of thoracic surgery.

[21]  Christopher E. Buller,et al.  Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2006, Circulation.

[22]  S. Hagl,et al.  Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. , 2008, European heart journal.

[23]  Francesco Maisano,et al.  Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[24]  A. Galloway,et al.  High-risk aortic valve replacement: are the outcomes as bad as predicted? , 2008, The Annals of thoracic surgery.

[25]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.